Influence of industry on renal guideline development

被引：65

作者：

Coyne, Daniel W. ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA

来源：

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 2卷 / 01期

关键词：

D O I：

10.2215/CJN.02170606

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3 / 7

页数：5

共 41 条

[1]

[Anonymous], 2001, Am J Kidney Dis, V37, pS182

[2]

[Anonymous], AM J KIDNEY DIS

[3]

Armstrong David, 2006, Wall St J (East Ed), pA9

[4]

ARONSON N, 2001, AHRQ PUBLICATION

[5] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].

Besarab, A ;

Bolton, WK ;

Browne, JK ;

Egrie, JC ;

Nissenson, AR ;

Okamoto, DM ;

Schwab, SJ ;

Goodkin, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590

[6] Management of conflict of interest issues in the activities of the American Heart Association Emergency Cardiovascular Care Committee, 2000 2005 [J].

Billi, JE ;

Eigel, B ;

Montgomery, WH ;

Nadkarni, VM ;

Hazinski, MF .

CIRCULATION, 2005, 112 (24) :IV204-IV205

[7]

Block GA, 2006, CLIN GUIDE BASICS BO, P77

[8] Doctors and drug companies [J].

Blumenthal, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (18) :1885-1890

[9] Relationships between authors of clinical practice guidelines and the pharmaceutical industry [J].

Choudhry, NK ;

Stelfox, HT ;

Detsky, AS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (05) :612-617

[10]

DAVITA I, 2006, 2005 ANN REP FORM K1

← 1 2 3 4 5 →